Zurich, Switzerland

Matthias Valentin Westphal


Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Zurich, CH (2016 - 2019)
  • Zürich, CH (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
5 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Matthias Valentin Westphal:

Title: Unveiling the Innovations of Matthias Valentin Westphal

Introduction:

Matthias Valentin Westphal is a prolific inventor based in Zurich, Switzerland. With an impressive total of 5 patents to his name, Westphal has been making significant contributions to the field of medicinal compounds and pharmacology.

Latest Patents:

1. [1,2,3]triazolo[4,5-d]pyrimidine derivatives: Westphal's recent innovation involves a groundbreaking compound of formula (I) that demonstrates potential for medicinal use, with R to R' as crucial defining factors.

2. [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor: Another notable patent by Westphal includes a compound of formula (I) exhibiting affinity for the type-2 cannabinoid receptor, opening new avenues in pharmacological research.

Career Highlights:

Currently employed at Hoffmann-La Roche Inc., a renowned pharmaceutical company, Westphal continues to drive innovation and excellence in the industry. His dedication to advancing medical science is truly commendable.

Collaborations:

Westphal's professional journey is marked by collaborations with esteemed colleagues such as Uwe Grether and Luca Claudio Gobbi. Together, they have contributed to the development of cutting-edge pharmaceutical solutions.

Conclusion:

In conclusion, Matthias Valentin Westphal's impressive portfolio of patents underscores his status as a visionary inventor in the realm of medicinal compounds. His work not only showcases his scientific prowess but also highlights his unwavering commitment to improving healthcare and advancing pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…